SCHEMBL845598

SCHEMBL845598

Cc1nnsc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3snnc3C)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.46
GFER P55789 1/20 0.46
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
MEN1 O00255 2/20 0.45
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPC1 O15118 1/20 0.44
TSHR P16473 1/20 0.43
MAPT P10636 1/20 0.42
RHOC P08134 1/20 0.42
RHOA P61586 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845325 0.93 KMT2A (0.43) RAB9AGFERKMT2AALDH1A1MAPK1
SCHEMBL845422 0.84 KMT2A (0.46) KMT2AALDH1A1MAPK1HTTCYP2C9
SCHEMBL845592 0.81 KMT2A (0.64) KMT2AALDH1A1MAPK1HTTMEN1
SCHEMBL845403 0.78 GFER (0.46) GFERALDH1A1CYP2C9CYP2C19NPC1
SCHEMBL845258 0.78 MAPK1 (0.60) KMT2AALDH1A1MAPK1HTTMEN1
SCHEMBL844980 0.78 ALDH1A1 (0.45) KMT2AALDH1A1MAPK1HTTMEN1
SCHEMBL845421 0.78 ALDH1A1 (0.42) KMT2AALDH1A1MAPK1HTTMEN1
SCHEMBL845008 0.78 ALDH1A1 (0.54) KMT2AALDH1A1MAPK1HTTMEN1
SCHEMBL845295 0.77 KDM4E (0.61) KMT2AALDH1A1MAPK1HTTMEN1
SCHEMBL845338 0.77 RHOC (0.48) KMT2AALDH1A1CYP2C9CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed